Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about disclosure

27 Jan 2023 Evaluate
Ajanta Pharma has informed that exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on January 25, 2023 for Aayush Agrawal, trustee Aayush Agrawal Trust.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1760.00
Dr. Reddys Labs. 1305.00
Cipla 1350.00
Lupin 1959.05
Zydus Lifesciences 1167.00
View more..